<div><strong>Tom is in a race against time.</strong>
</div>
<div><br />
</div>
<div><strong>ALS is taking away his independence and physical strength.</strong>
</div>
<div><strong>But there is still a small window of hope.</strong>
</div>
<div><br />
</div>
<div><strong>A medication called Tofersen can slow the progression of his disease.</strong>
</div>
<div><strong>But where we live, he cannot access it.</strong>
</div>
<div><br />
</div>
<div><strong>Our closest option to treatment is Germany, where the medication is approved. But as an international patient, we must cover all costs ourselves.</strong>
</div>
<div><br />
</div><img alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/100978795_1777554697193747_r.png" width="100%" />
<div><br />
</div>
<div>The Swedish newspaper Aftonbladet recently featured Tom in an article about how patients are being forced to seek treatment abroad: <strong><a href="https://www.aftonbladet.se/nyheter/a/Wvj5Oa/lakemedel-mot-als-raddar-liv-stoppas-i-sverige" target="_blank" rel="noreferrer noopener">Tofersen Article</a></strong>
</div>
<div><br />
</div><img alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/100978795_1775213408791145_r.png" width="100%" />
<div><strong>How You Can Help</strong>
</div>
<div><br />
</div>
<div>ALS moves quickly, and time is something we cannot get back.
</div>
<div><br />
</div>
<div>We are raising<strong> $380,000 (3.5 million SEK)</strong> to secure one year of <strong>Tofersen</strong> <strong>in Germany</strong> — giving Tom the chance to start treatment while there is still time.
</div>
<div><br />
</div>
<div>These funds will help cover:
</div>
<div>• One year of Tofersen injections
</div>
<div>• Monthly travel between Sweden and Germany
</div>
<div>• Essential support during treatment overseas
</div>
<div><br />
</div><img alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/100978795_1775213479460515_r.jpeg" width="100%" />
<div><strong>The love of my life</strong>
</div>
<div><br />
</div>
<div>My name is Tamara, and I am an American-Swede living in Stockholm together with my husband Tom.
</div>
<div><br />
</div>
<div>For over three decades, our love has carried us across countries and distances, shaping a life together across two continents.
</div>
<div>With each year, our bond has only deepened and grown stronger.
</div>
<div><br />
</div>
<div>Tom is the love of my life — my forever person, my partner in everything.
</div>
<div>But today, I am not only his wife.
</div>
<div>I am his full-time caregiver — and an advocate in the fight against ALS.
</div>
<div><br />
</div><img alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/100978795_1781702697241798_r.jpg" width="100%" />
<div><strong>This is Tom</strong>
</div>
<div><br />
</div>
<div>Tom has always been a person you can count on. As a mechanical engineer, he has spent his life solving complex problems and keeping critical systems running. The same mindset defines him outside of work — when something breaks, Tom is the one who steps in with a calm, focused manner and makes things work again.
</div>
<div><br />
</div>
<div>Tom has always had a soft spot for animals, and our Bengal cat Lakrits (Liquorice) has become far more than a pet during this journey. She seems to sense exactly when Tom needs her and rarely leaves his side. In many ways, she has become one of the emotional anchors helping us get through each day.
</div><img alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/100978795_1775213649997396_r.jpeg" width="100%" /><img alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/100978795_1775213678389560_r.jpeg" width="100%" />
<div><strong>A Groundbreaking Clinical Trial in San Francisco</strong>
</div>
<div><br />
</div>
<div>With no treatment options available in Sweden, Tom chose to take part in an experimental clinical trial in the United States.
</div>
<div><br />
</div>
<div>In August 2024, we traveled to the <strong>Forbes Norris ALS Center in San Francisco,</strong> where Tom became one of the <strong>first patients in the world </strong>to receive a new gene therapy developed by UniQure.
</div>
<div><br />
</div>
<div>This was a first-in-human study focused solely on safety and research.
</div>
<div><br />
</div>
<div>While we did not see a clear clinical benefit for him, it was still a meaningful step — both for us and an opportunity for Tom to contribute to the future of medicine.
</div>
<div><br />
</div>
<div>He chose to participate despite the uncertainty and risks — not only for himself, but to help move ALS research forward for those who come after him.
</div><img alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/100978795_1775213717582497_r.jpeg" width="100%" /><img alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/100978795_177521375893589_r.png" width="100%" />
<div><strong>The ongoing fight</strong>
</div>
<div><br />
</div>
<div>Living with ALS is not only physically and emotionally overwhelming — it is financially draining.
</div>
<div><br />
</div>
<div>Since Tom’s diagnosis, I have stepped away from my career to care for him full-time. We have covered costs for equipment, care, travel, and medical needs ourselves.
</div>
<div><br />
</div>
<div>During the clinical trial year in San Francisco, we received a stipend for living expenses through the study, but still relied significantly on our personal savings.
</div>
<div><br />
</div>
<div>Today, as Tom’s primary caregiver, I manage all aspects of his care — treatments, logistics, and daily life
</div>
<div><br />
</div>
<div><strong>But this is something we cannot carry alone.</strong>
</div>
<div><br />
</div>
<div><strong>We are facing a complex and urgent path—navigating system gaps, borders, regulations, and limited time—while doing everything we can to move forward.</strong>
</div>
<div><br />
</div>
<div><strong>To make this possible, we are asking for your support.</strong>
</div>
<div><br />
</div>
<div><strong>Any contribution—no matter the size—will help bring Tom closer to treatment overseas. <em>Because no one’s chance at treatment should depend on geography.</em></strong>
</div>
<div><br />
</div>
<div><strong>If you’re unable to donate, sharing Tom’s story and keeping him in your thoughts means just as much.</strong>
</div>
<div><br />
</div>
<div>From the bottom of our hearts, thank you for standing with us.
</div>
<div><br />
</div>
<div>With love and gratitude,
</div>
<div>Tamara &amp; Tom
</div><img alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/100978795_1775213800881383_r.jpeg" width="100%" />

Anonymous

Christian Lawaetz

Allison Bulat

Svetlana Tyuleneva

Lorraine Noriega

Leonard Erskine

Frode Magnell

Douglas Askelöf

Malgorzata Auguscinska

Hilde Birgitte Olsen

Marcela Paranto

Josef Csongei

Therese Virserius

Malin Carlsson

Mårten Lundberg

Madelene Hansson

Jan Hansen

Help Tom Access Treatment for His Rare ALS

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

currencyCode

Money Box Donation List Prompt Experiment Audience

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

International Only

fundId

braze fundraiser group 

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Sitewide Banner: en_*

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

displayName

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

PODO share impact with donation

Posters INTL

Support Comments Allowlist

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

NPO upsell education category

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

checkout headers audience

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

categoryGroup

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

NPO email opt-in candidates

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

campaignId

P2P Moments Test Campaign

Spanish Speakers

NPO upsell animals category

NPO upsell disaster relief category

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

NPO upsell essential needs category

NPO upsell medical category

userCurrencyCode

Localized Currency

NPO upsell cancer category

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

You’re supporting Help Tom Access Treatment for His Rare ALS

Your donation will benefit Tamara Sayiner